NOVEL METHOD FOR EFFICIENT PURIFICATION OF HUMAN SERUM ALBUMIN

(19)

(11)

EP 3 240 798 B8

(12)	CORRECTED EUROPEAN PATENT SPECIFICATION
	Note: Bibliography reflects the latest situation

(15)	Correction information:
	Corrected version no 1 (W1 B1)

(48)	Corrigendum issued on:
	25.03.2020 Bulletin 2020/13

(45)	Mention of the grant of the patent:
	12.02.2020 Bulletin 2020/07

(21)	Application number: 16732884.8

(22)	Date of filing: 01.01.2016

(51)

International Patent Classification (IPC):

C07K 1/16^(2006.01)
C07K 1/20^(2006.01)
C07K 14/76^(2006.01)
B01D 15/36^(2006.01)
C07K 1/34^(2006.01)
B01D 15/12^(2006.01)

C07K 1/18^(2006.01)
C07K 19/00^(2006.01)
B01D 15/32^(2006.01)
C07K 14/765^(2006.01)
C07K 1/36^(2006.01)
B01D 15/42^(2006.01)

(86)	International application number:
	PCT/IB2016/050001

(87)	International publication number:
	WO 2016/108211 (07.07.2016 Gazette 2016/27)

(54)	NOVEL METHOD FOR EFFICIENT PURIFICATION OF HUMAN SERUM ALBUMIN NEUARTIGES VERFAHREN ZUR EFFIZIENTEN AUFREINIGUNG VON HUMANEM SERUMALBUMIN NOUVEAU PROCÉDÉ DE PURIFICATION EFFICACE DE SÉRUMALBUMINE HUMAINE

(84)	Designated Contracting States:
	AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

(30)

Priority:

01.01.2015 IN 3228CH2014

(43)	Date of publication of application:
	08.11.2017 Bulletin 2017/45

(73)	Proprietor: Shilpa Medicare Limited
	Karnataka 584135 (IN)

(72)	Inventor:
	KARUR, Rajyashri Ramakrishna Hubli 580031 (IN)

(74)	Representative: Lecca, Patricia S.
	Cabinet Lecca 21, rue de Fécamp 75012 Paris 75012 Paris (FR)

(56)

References cited: :

EP-A1- 0 612 761
EP-B1- 0 650 736
CN-B- 101 768 206

EP-A2- 0 570 916
WO-A1-93/01207
US-A- 5 612 196

AKINORI A ET AL: "Purification of recombinant human serum albumin. Efficient purification using STREAMLINE", BIOSEPARATION, KLUWER ACADEMIC PUBLISHERS, DORDRECHT, NL, vol. 8, no. 1, 1 January 1999 (1999-01-01) , pages 195-200, XP002345866, ISSN: 0923-179X, DOI: 10.1023/A:1008081314112
TONG HONG-FEI ET AL: "Caprylate as the albumin-selective modifier to improve IgG purification with hydrophobic charge-induction chromatography", JOURNAL OF CHROMATOGRAPHY A, ELSEVIER, AMSTERDAM, NL, vol. 1285, 15 February 2013 (2013-02-15), pages 88-96, XP028996084, ISSN: 0021-9673, DOI: 10.1016/J.CHROMA.2013.02.023
GERALD A. BALLOU ET AL: "CHEMICAL, CLINICAL, AND IMMUNOLOGICAL STUDIES ON THE PRODUCTS OF HUMAN PLASMA FRACTIONATION. V. THE INFLUENCE OF NON-POLAR ANIONS ON THE THERMAL STABILITY OF SERUM ALBUMIN 123", JOURNAL OF CLINICAL INVESTIGATION, vol. 23, no. 4, 1 July 1944 (1944-07-01), pages 454-457, XP055512410, ISSN: 0021-9738, DOI: 10.1172/JCI101512
YUESHENG DONG ET AL: "Extraction and purification of recombinant human serum albumin frombroths using aqueous two-phase system combined with hydrophobic interaction chromatography", JOURNAL OF CHROMATOGRAPHY A, ELSEVIER, AMSTERDAM, NL, vol. 1245, 10 May 2012 (2012-05-10), pages 143-149, XP028521242, ISSN: 0021-9673, DOI: 10.1016/J.CHROMA.2012.05.041 [retrieved on 2012-05-15]
HIDAYAT ULLAH KHAN: 'The Role of Ion Exchange Chromatography in Purification and Characterization of Molecules' ION EXCHANGE TECHNOLOGIES 2012, page 340, XP055466580

Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).